Marion Boulicault
Biographic Data
| ID | 1268445 |
|---|---|
| NAME | Marion Boulicault |
| GIVEN NAMES | Marion |
| FAMILY NAME | Boulicault |
| SIGNATURE | BOULICAULT M |
| AFFILIATIONS | University of Edinburgh |
| ORCID | 0000-0001-5990-2373 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 17 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 2 |
Does Menstrual Cycle Tracking Enhance Female Athlete Health and Performance? Evaluating Five Implicit Assumptions of an Emerging Paradigm
Sex in the medical machine: How algorithms can entrench bioessentialism in precision medicine
Machine learning offers new possibilities for developing more precise diagnostics and treatments, but the increasing use of sex stratification in precision medicine algorithms raises concerns. Using Alzheimer's disease (AD) research as an example in which machine learning approaches are applied to a heterogenous, socially patterned disease, this paper examines how the move toward sex-specific “pink” and “blue” algorithms reinforces biological sex…
The New Genetics of Sexuality
In 2019 a “genetic app” titled “How Gay Are You?” was published on GenePlaza (Maxmen 2019), immediately following the publication of a headline-making genetics study on same-sex sexual behavior (Ganna et al. 2019; Belluck 2019). In response to widespread outrage, the app was quickly discontinued (Bellenson 2019). But, rather than a rogue misapplication of responsible science—as the study's authors and others decried it—this debacle is emblematic …
Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology
The U.S. Food and Drug Administration's (FDA) 2013 decision to lower recommended Ambien dosing for women has been widely cited as a hallmark example of the importance of sex differences in biomedicine. Using regulatory documents, scientific publications, and media coverage, this article analyzes the making of this highly influential and mobile 'sex-difference fact'. As we show, the FDA's decision was a contingent outcome of the drug approval proc…
A Gender Hypothesis of sex disparities in adverse drug events
A Feminist Approach to Analyzing Sex Disparities in Covid-19 Outcomes
How Cumulative Statistics Can Mislead: The Temporal Dynamism of Sex Disparities in Covid-19 Mortality in New York State
Overall, men have died from COVID-19 at slightly higher rates than women. But cumulative estimates of mortality by sex may be misleading. We analyze New York State COVID-19 mortality by sex between March 2020 and August 2021, demonstrating that 72.7% of the total difference in the number of COVID-19 deaths between women and men was accrued in the first seven weeks of the pandemic. Thus, while the initial surge in COVID-19 mortality was characteri…
Sex disparities in Covid-19 outcomes in the United States: Quantifying and contextualizing variation
Social Trust
What makes science trustworthy to the public? This chapter examines one answer: the trustworthiness of science is based in part on its independence from the idiosyncratic values, wishes and interests of individual scientists. That is, science is trustworthy to the extent that following the scientific method would result in the same conclusions, regardless of the particular scientists involved. This “idiosyncrasy-free ideal” (IFI) for science has …
Sex disparities in Covid-19 outcomes in the United States: Quantifying and contextualizing variation
Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology
The U.S. Food and Drug Administration's (FDA) 2013 decision to lower recommended Ambien dosing for women has been widely cited as a hallmark example of the importance of sex differences in biomedicine. Using regulatory documents, scientific publications, and media coverage, this article analyzes the making of this highly influential and mobile 'sex-difference fact'. As we show, the FDA's decision was a contingent outcome of the drug approval proc…
A Gender Hypothesis of sex disparities in adverse drug events
Social Trust
What makes science trustworthy to the public? This chapter examines one answer: the trustworthiness of science is based in part on its independence from the idiosyncratic values, wishes and interests of individual scientists. That is, science is trustworthy to the extent that following the scientific method would result in the same conclusions, regardless of the particular scientists involved. This “idiosyncrasy-free ideal” (IFI) for science has …
Social Trust
What makes science trustworthy to the public? This chapter examines one answer: the trustworthiness of science is based in part on its independence from the idiosyncratic values, wishes and interests of individual scientists. That is, science is trustworthy to the extent that following the scientific method would result in the same conclusions, regardless of the particular scientists involved. This “idiosyncrasy-free ideal” (IFI) for science has …
A Feminist Approach to Analyzing Sex Disparities in Covid-19 Outcomes
How Cumulative Statistics Can Mislead: The Temporal Dynamism of Sex Disparities in Covid-19 Mortality in New York State
Overall, men have died from COVID-19 at slightly higher rates than women. But cumulative estimates of mortality by sex may be misleading. We analyze New York State COVID-19 mortality by sex between March 2020 and August 2021, demonstrating that 72.7% of the total difference in the number of COVID-19 deaths between women and men was accrued in the first seven weeks of the pandemic. Thus, while the initial surge in COVID-19 mortality was characteri…
Sex disparities in Covid-19 outcomes in the United States: Quantifying and contextualizing variation
Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology
The U.S. Food and Drug Administration's (FDA) 2013 decision to lower recommended Ambien dosing for women has been widely cited as a hallmark example of the importance of sex differences in biomedicine. Using regulatory documents, scientific publications, and media coverage, this article analyzes the making of this highly influential and mobile 'sex-difference fact'. As we show, the FDA's decision was a contingent outcome of the drug approval proc…
A Gender Hypothesis of sex disparities in adverse drug events
The New Genetics of Sexuality
In 2019 a “genetic app” titled “How Gay Are You?” was published on GenePlaza (Maxmen 2019), immediately following the publication of a headline-making genetics study on same-sex sexual behavior (Ganna et al. 2019; Belluck 2019). In response to widespread outrage, the app was quickly discontinued (Bellenson 2019). But, rather than a rogue misapplication of responsible science—as the study's authors and others decried it—this debacle is emblematic …
Sex in the medical machine: How algorithms can entrench bioessentialism in precision medicine
Machine learning offers new possibilities for developing more precise diagnostics and treatments, but the increasing use of sex stratification in precision medicine algorithms raises concerns. Using Alzheimer's disease (AD) research as an example in which machine learning approaches are applied to a heterogenous, socially patterned disease, this paper examines how the move toward sex-specific “pink” and “blue” algorithms reinforces biological sex…
Does Menstrual Cycle Tracking Enhance Female Athlete Health and Performance? Evaluating Five Implicit Assumptions of an Emerging Paradigm
Medicine (5 works) · Sociology (5 works) · Political science (4 works) · Sex and Gender in Healthcare (4 works) · Coronavirus disease 2019 (COVID-19 (3 works) · Demography (3 works) · Demography (3 works) · Biology (2 works) · COVID-19 Impact on Reproduction (2 works) · Gender Studies (2 works)